drugset / Trial / NCT03883945
A Safety and Efficacy Study to Evaluate Rosacea
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the safety, efficacy, and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with rosacea.
Timeline
- Start
- 2021-07
- Primary completion
- 2022-07
- Completion
- 2022-08
Outcome
Outcome not reported
Stopped: “Sponsor deprioritization”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AIV001 | Unknown | 0.01 % | Other |
| Comparator | AIV001 | Unknown | 0.03 % | Other |
| Comparator | AIV001 | Unknown | 0.033 % | Other |